Euflexxa vs Hyalgan – A Thorough Comparison

Last Updated On: September 10, 2024

Mobility hinges on a delicate balance that relies on the synergy of joints, cartilage, and synovial fluid. Research consistently underscores the vital importance of lubrication and shock absorption in maintaining pain-free movement. 

Euflexxa and Hyalgan are two intra-articular injections designed to alleviate knee osteoarthritis (OA) symptoms. Both treatments offer hope to those seeking relief from OA-related pain and stiffness. Comparing their efficacy, side effects, and treatment regimens can help determine the most suitable option for individual patient needs. 

In this article, we’ll delve into the nuances of Euflexxa and Hyalgan, focusing on their mechanisms of action to clinical efficacy as well as their benefits and potential side effects.

Key Takeaways

• Euflexxa and Hyalgan are both hyaluronic acid-based viscosupplements used to alleviate knee osteoarthritis symptoms by providing lubrication and cushioning in the joint, mimicking natural synovial fluid.
• Studies have shown the efficacy and safety of both Euflexxa and Hyalgan in treating knee osteoarthritis, with patients experiencing significant pain relief and improved mobility.
• Practical considerations such as dosing requirements, monitoring side effects, post-injection care, treatment efficacy evaluation, and cost considerations are important when comparing Euflexxa and Hyalgan for individual patient needs.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. Order Euflexxa at Med Supply Solutions today and stock your practice at wholesale prices!

Introduction to Euflexxa and Hyalgan

Osteoarthritis (OA) is a degenerative joint disease causing pain, stiffness, and reduced mobility. Viscosupplements, such as hyaluronic acid (HA) injections, offer an effective treatment by providing lubrication and cushioning in the joint, mimicking natural synovial fluid.

Euflexxa and Hyalgan are two well-known HA-based viscosupplements used to treat OA. Euflexxa is a bioengineered, non-avian product designed to improve joint function and alleviate pain. Similarly, Hyalgan is derived from rooster combs and provides pain relief and improved mobility through injections into the affected joint.

Composition and Mechanism of Action

Euflexxa is a non-avian-derived hyaluronic acid (HA) product that closely mimics the natural HA found in human joints. Its formulation is designed for high purity and consistency. When injected into the joint, Euflexxa acts as a lubricant and shock absorber, reducing pain and improving joint mobility. The mechanism involves restoring the viscoelastic properties of the synovial fluid, thus facilitating smoother joint movement.

Hyalgan, derived from rooster combs, also consists of HA. It shares a similar mechanism of action by supplementing the natural synovial fluid within the joint. Hyalgan’s HA helps to cushion and lubricate the joint, thereby alleviating pain and enhancing mobility. It also stimulates the endogenous production of HA, contributing to long-term joint health.

Clinical Efficacy and Safety Profiles

A double-blind, randomized study assessed Euflexxa’s efficacy and safety in treating knee osteoarthritis with three weekly injections of Euflexxa or saline. Results, last updated in 2011, aimed to compare Euflexxa with saline. For the most current advice, consult a healthcare professional, as the information is based on studies conducted up to that date.

Similarly, an open-label extension study followed the FLEXX Trial and assessed the safety and efficacy of retreatment with Euflexxa. The results indicated favorable outcomes for patients with painful knee osteoarthritis. 

As for Hyalgan, a pivotal trial revealed that two out of three patients receiving Hyalgan reported significant pain relief lasting up to 6 months. During a 50-foot walk, mean pain scores significantly improved compared to placebo over 26 weeks. Moreover, repeat treatment with Hyalgan demonstrated sustained pain reduction for up to 30 months. 

Multimodal treatment, which includes hyaluronic acid (HA), yielded positive outcomes. Patients with Kellgren-Lawrence grades I to III experienced a 53% to 55% improvement in mean WOMAC pain scores, while grade IV patients showed a 46% improvement. Importantly, very low rates of total knee replacement were observed at 1 and 2 years post-treatment. 

Additionally, economic analyses indicated that Hyalgan remained cost-effective at the 2-year mark. 

Practical Considerations

Euflexxa and Hyalgan are both used to treat knee pain caused by osteoarthritis. They act as viscosupplements, injected directly into the knee joint.

• Euflexxa Dosage Requirements: Administer Euflexxa as three weekly injections to lubricate and cushion the knee joint.
• Hyalgan Treatment Schedule: Hyalgan requires five weekly injections to restore knee joint fluid properties.
• Monitoring Side Effects: Monitor for common side effects like injection site pain and swelling, and rare severe reactions.
• Post-Injection Care: Advise avoiding strenuous activities for 48 hours post-injection to reduce discomfort and swelling.
• Assessing Treatment Efficacy: Evaluate knee pain and mobility improvements about four weeks after the final injection.
• Considering Repeat Treatments: Discuss repeating treatments if symptoms return, based on follow-up evaluations.
• Cost Considerations for Patients: Before starting, inform patients about treatment costs and insurance coverage variations.
• Patient Education on Treatment Options: Discuss expectations and potential for repeated courses with Euflexxa vs. Hyalgan.
• Reviewing Patient Satisfaction Scores: Use patient satisfaction scores to guide decisions on Euflexxa vs. Hyalgan.
• Evaluating Generic Alternatives: Note that Euflexxa has no generic version, and explore other treatment options.

Patient Satisfaction with Euflexxa and Hyalgan

Both Euflexxa and Hyalgan aim to alleviate the pain of osteoarthritis through their viscosupplementation properties but they do so in ways that resonate differently with patients.

On Euflexxa

• Jim C.: “…There a quite a few comments about people being concerned about the injections being painful. That has NOT been the case for me. The injections of the Euflexxa are a little thicker and take a little bit longer to inject but it is not painful. There is a feeling of additional pressure in the joint but it does not hurt.…”
• Ed: “…Tried Euflexxa this time and have had much better success lasting at least 7 years both times. Now I live in Ga and need injections again and will be getting Euflexxa again. Can’t mess with success…”

On Hyalgan

• Lonepunter: “Works great for me! I walk 3 miles in the morning with my wife almost every day and jog 3 miles in the afternoon 5 to 6 days a week, also 2 aerobic step classes every week for the past 5 years…”
• Anonymous: “Hyalgan injections have worked for me immensely! My first round of 3 lasted a year. I just started my second round as I had a flare up. I hear some orthopedic surgeons feel there is no proof that it works and are convincing the insurance companies not to cover Hyalgan…”

Cost Comparison

The comparison between Euflexxa and Hyalgan is crucial for medical professionals to make informed decisions on behalf of their patients, considering both efficacy and economic factors.

Conclusion

Choosing between Euflexxa and Hyalgan, or even between Euflexxa vs Supartz, involves considering their effectiveness, safety, and cost. Euflexxa may provide slightly better pain relief, while Hyalgan is also effective and safe. Costs vary, so consider patient affordability. Relief duration differs, so treatment is selected based on the patient’s health needs and budget.

FAQs

1. What is the difference between Euflexxa and Hyalgan? 

Euflexxa and Hyalgan are distinct treatments for joint pain, each with different generic names, prescribing information, and potential side effects.

2. What are Euflexxa’s side effects? 

Euflexxa may cause side effects, which can vary among individuals. Consult your healthcare provider for specific details and guidance.

3. How does Euflexxa compare to Monovisc or Supartz? 

Euflexxa differs from Monovisc and Supartz in aspects such as efficacy, cost-effectiveness, and patient tolerance. Comparing these factors helps determine the most suitable treatment.

4. Where can I find Euflexxa’s prescribing information? 

Euflexxa’s prescribing information, detailing dosage, usage instructions, and contraindications, is available on pharmaceutical websites and through your healthcare provider.

References

How to Lubricate Stiff Joints: Unlocking the Secrets to Pain-Free Move. Physio Flex Pro. Published August 21, 2023. Accessed July 26, 2024. https://physioflexpro.com/blogs/joint-care/how-to-lubricate-stiff-joints 

Rehman S ur, Iqbal S, Shahid MU, Jahangir MS, Malik AL. Cartilage: Structure, Function, and the Pathogenesis of Osteoarthritis. www.intechopen.com. Published January 23, 2024. https://www.intechopen.com/chapters/1165716